BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 18802419)

  • 1. Genomics, public health and developing countries: the case of the Mexican National Institute of Genomic Medicine (INMEGEN).
    Séguin B; Hardy BJ; Singer PA; Daar AS
    Nat Rev Genet; 2008 Oct; 9 Suppl 1():S5-9. PubMed ID: 18802419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translational Genomics in Low- and Middle-Income Countries: Opportunities and Challenges.
    Tekola-Ayele F; Rotimi CN
    Public Health Genomics; 2015; 18(4):242-7. PubMed ID: 26138992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing a platform for genomic medicine in Mexico.
    Jimenez-Sanchez G
    Science; 2003 Apr; 300(5617):295-6. PubMed ID: 12690190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic medicine in Mexico: initial steps and the road ahead.
    Jimenez-Sanchez G; Silva-Zolezzi I; Hidalgo A; March S
    Genome Res; 2008 Aug; 18(8):1191-8. PubMed ID: 18676818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic medicine and developing countries: creating a room of their own.
    Séguin B; Hardy BJ; Singer PA; Daar AS
    Nat Rev Genet; 2008 Jun; 9(6):487-93. PubMed ID: 18487990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profile: Mexico's National Institute of Public Health at 30.
    Rubin R
    Lancet; 2017 Feb; 389(10071):787. PubMed ID: 28248165
    [No Abstract]   [Full Text] [Related]  

  • 7. Population, petroleum, and politics: Mexico at the crossroads. Part 2. The potentials and problems of Mexican oil resources.
    Gallagher CF
    Am Univ Field Staff Rep North Am; 1980; (42):1-16. PubMed ID: 12310262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic Medicine Without Borders: Which Strategies Should Developing Countries Employ to Invest in Precision Medicine? A New "Fast-Second Winner" Strategy.
    Mitropoulos K; Cooper DN; Mitropoulou C; Agathos S; Reichardt JKV; Al-Maskari F; Chantratita W; Wonkam A; Dandara C; Katsila T; Lopez-Correa C; Ali BR; Patrinos GP
    OMICS; 2017 Nov; 21(11):647-657. PubMed ID: 29140767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Opportunities for the pharmaceutical industry at the Mexican Genomic Medicine Institute].
    Jiménez-Sánchez G
    Gac Med Mex; 2002; 138(3):291-4. PubMed ID: 12096400
    [No Abstract]   [Full Text] [Related]  

  • 11. Decree of the National Institute of Perinatology, 14 July 1988.
    Mexico. Ministerio de Salud
    Annu Rev Popul Law; 1988; 15():209-10. PubMed ID: 12289414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genomic medicine in public health policies: a perspective of Mexican biomedical researchers].
    Oliva-Sánchez PF; Siqueiros-García JM; Vázquez-González JR; Saruwatari-Zavala G; Carnevale A
    Salud Publica Mex; 2013; 55(1):16-25. PubMed ID: 23370255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An innovative approach to public health research: the case of a new center in Mexico.
    Frenk J; Bobadilla JL; Sepúlveda J; Rosenthal J; Ruelas E; González-Block MA; Urrusti J
    J Health Adm Educ; 1986; 4(3):467-81. PubMed ID: 10278635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The law of genomic sovereignty and the protection of "Mexican genetic patrimony".
    Schwartz-Marín E; Méndez AA
    Med Law; 2012 Jun; 31(2):283-94. PubMed ID: 22900414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roadmap for Establishing Large-Scale Genomic Medicine Initiatives in Low- and Middle-Income Countries.
    Patrinos GP; Pasparakis E; Koiliari E; Pereira AC; Hünemeier T; Pereira LV; Mitropoulou C
    Am J Hum Genet; 2020 Oct; 107(4):589-595. PubMed ID: 33007198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mexico.
    United States. Department of State. Bureau of Public Affairs
    Backgr Notes Ser; 1988 Feb; ():1-8. PubMed ID: 12177969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The End of Insurance? Mexico's Seguro Popular, 2001 - 2007.
    Lakin JM
    J Health Polit Policy Law; 2010 Jun; 35(3):313-52. PubMed ID: 20498304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Equity, public health and genomics: the legal, social and biotechnology challenge in México].
    Oliva-Sánchez PF; Jafif-Cojab M; Akkad-Schaffer I; Waliszewski-Zamorano E
    Gac Med Mex; 2013; 149(5):562-8. PubMed ID: 24108344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mexican population: 1982.
    Sanders TG
    Am Univ Field Staff Rep North Am; 1982; (34):1-14. PubMed ID: 12312081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eradication, control or neither? Hookworm vs malaria strategies and Rockefeller Public Health in Mexico.
    Birn AE
    Parassitologia; 1998 Jun; 40(1-2):137-47. PubMed ID: 9653741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.